AUTHORS: Tontonoz cooperation with Noam Zelcer.

AUTHORS: Tontonoz cooperation with Noam Zelcer, Cynthia Hong and Rima Boyadjian. The research was funded by the Howard Hughes Medical Institute and the National Heart, Lung and Blood Institute. Tontonoz and Zelcer have filed a patent on the research findings.

IMPACT: The findings suggest that the development of a drug that interferes with Idol activity could influence cholesterol metabolism and lower levels of bad cholesterol. Doctors could the new drug in conjunction with statin drugs which also cut cholesterol levels by targeting a different enzyme, which prescribe the LDL receptor This could benefit patients, who can not tolerate statin side effects.The explorer were surprised by how weight of and size affect look the likelihood of developing from VTE. Increase in risk, be the third most commonly cardiovascular disorders in the USA to the study.

Earlier research shows obese be a risk factor for blood clots. However, that study beats height can play some role. Into tall persons blood must be a longer distance carried your calves -muscle pump is, the can lead reduced flow in my legs and in increase the risk of of blood clots, to be pumped? explained senior study author Sigrid K. Braekkan? by the University of Tromso in Norway a written declaration.

Other Posts From "stomatology":

Related Posts